CHU de Reims — Reims

Public research footprint of CHU de Reims, compiled from the ClinicalTrials.gov public registry.

288

Registered studies

Active

Recruiting now

146

Completed

Stopped or withdrawn

Most-studied conditions

Ulcerative Colitis Chronic · Relapsed or Refractory Follicular Lymphoma · Immunoglobulin A Nephropathy (IgAN) · Early Alzheimer's Disease

Recently updated registry entries

NCT04526665 — Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (Active Not Recruiting)
NCT05443087 — TARGETed Therapy Drug MONITOring in DIGestive Oncology (Recruiting)
NCT04487639 — Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Reims?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.